MEDIWOUND ($MDWD) posted quarterly earnings results on Wednesday, May 21st. The company reported earnings of -$0.07 per share, beating estimates of -$0.66 by $0.59. The company also reported revenue of $3,960,000, missing estimates of $5,184,252 by $-1,224,252.
You can see Quiver Quantitative's $MDWD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDIWOUND Hedge Fund Activity
We have seen 33 institutional investors add shares of MEDIWOUND stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 159,691 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,478,404
- ROSALIND ADVISORS, INC. removed 121,157 shares (-19.3%) from their portfolio in Q1 2025, for an estimated $1,880,356
- WELLS FARGO & COMPANY/MN removed 75,208 shares (-84.1%) from their portfolio in Q1 2025, for an estimated $1,167,228
- BALYASNY ASSET MANAGEMENT L.P. removed 60,141 shares (-36.3%) from their portfolio in Q1 2025, for an estimated $933,388
- SARGENT INVESTMENT GROUP, LLC removed 52,500 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $814,800
- J. GOLDMAN & CO LP removed 45,901 shares (-77.8%) from their portfolio in Q1 2025, for an estimated $712,383
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. removed 37,760 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $586,035
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
